Search for share prices

Finance SearchWed, Nov 25, 2009, 7:55PM ET - U.S. Markets Closed.

4:00pm ET: 8.45

0.05 (0.60%)

VIVUS Inc. (VVUS)

More OnVVUS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Javascript is disabled on your browser.

The Interactive Chart requires Javascript to be enabled on your browser. You can use the Basic Chart, or follow the directions below to enable Javascript and use the Interactive Chart.

To enable Javascript in Internet Explorer 5.5 or higher...

1. Click Tools, then click Internet Options.
2. Click the Security tab.
3. Click the Custom Level button.
4. Scroll to the Scripting section.
5. Check Enable under Active scripting, Allow paste operations via script, and Scripting of Java applets.
6. Click the OK button.

To enable Javascript in Firefox 1.0 or higher...

1. Click Tools, then click Options.
2. Check Enable Javascript.
3. Click the OK button.

After enabling Javascript, click here to use the Interactive Chart.

Compare VVUS to:

Dow Jones (^DJI)
NASDAQ (^IXIC)
S&P 500 (^GSPC)

VIVUS, Inc.

(NasdaqGM: VVUS)

After Hours: 8.45 0.00 (0.00%) 7:21pm ET

Last Trade:	8.45
Trade Time:	4:00pm ET
Change:	0.05 (0.60%)
Prev Close:	8.40
Open:	8.45
Bid:	8.45 x 100
Ask:	8.45 x 200
1y Target Est:	13.57

Day's Range:	8.31 - 8.55
52wk Range:	2.72 - 12.88
Volume:	1,802,921
Avg Vol (3m):	6,088,600
Market Cap:	680.64M
P/E (ttm):	N/A
EPS (ttm):	-0.68
Div & Yield:	N/A (N/A)

Quotes delayed, except where indicated otherwise. For consolidated real-time quotes (incl. pre/post market data), sign up for a free trial of Real-time Quotes.

Headlines

Wed 3:20pm	A Big Upgrade for Amylin Pharmaceuticalsat Motley Fool
Tue 4:12pm	VIVUS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online
Tue 2:00pm	3 Stocks Ready to Roarat Motley Fool
Mon, Nov 23	The Side Effect of Developing Obesity Drugsat Motley Fool
Mon, Nov 23	Poniard Finds Cash to Keep Lights On: BioBuzzat TheStreet.com
Mon, Nov 23	Cel-Sci Chairman Sells Stock, Despite Sweetheart Loan Deal: BioBuzzat TheStreet.com
Mon, Nov 23	FDA Issues New Obesity Drug Heart Warning: BioBuzzat TheStreet.com
Fri, Nov 20	Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research AnalystWall Street Transcript
Fri, Nov 20	Trading Review for Vivus Inc. Issued by Beacon EquityGlobeNewswire
Fri, Nov 20	Biotech Stock Mailbag: FDA Playbookat TheStreet.com

View MoreHeadlines for VVUS

Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.

Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page.Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.Real-Time quotes provided by BATS Exchange.Financials data provided by Edgar Online.Dividend data provided by Morningstar, Inc.Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI).International historical chart data, daily updates, fundFund summary, fund performance and Morningstar Index data provided by Morningstar.Analyst estimates data provided by Thomson Financial Network. All data povided by Thomson Financial Network is based solely upon research information provided by third party analysts. Yahoo! has not reviewed, and in no way endorses the validity of such data. Yahoo! and ThomsonFN shall not be liable for any actions taken in reliance thereon.All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.